Woodline Partners’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-104,831
Closed -$1.96M 653
2024
Q1
$1.96M Buy
+104,831
New +$2.42M 0.02% 425
2022
Q2
Sell
-77,866
Closed -$2.58M 875
2022
Q1
$2.58M Buy
+77,866
New +$2.93M 0.04% 344
2021
Q4
Sell
-34,813
Closed -$1.54M 775
2021
Q3
$1.54M Buy
+34,813
New +$1.6M 0.03% 444
2021
Q2
Sell
-234,434
Closed -$17.5M 626
2021
Q1
$17.5M Buy
234,434
+49,876
+27% +$4.09M 0.39% 75
2020
Q4
$16M Sell
184,558
-576
-0.3% -$42.5K 0.42% 76
2020
Q3
$11.3M Sell
185,134
-102,809
-36% -$5.21M 0.37% 80
2020
Q2
$12M Buy
287,943
+129,116
+81% +$4.69M 0.47% 64
2020
Q1
$4.56M Buy
158,827
+138,535
+683% +$8.02M 0.33% 90
2019
Q4
$1.47M Buy
+20,292
New +$2.5M 0.06% 103

Other funds holding SAGE